Archives
Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Improved disease-free survival seen among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
Significantly longer overall and progression-free survival seen among patients with limited-stage small cell lung cancer
Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma
Continued survival benefit seen for nivolumab plus ipilimumab and for nivolumab monotherapy versus ipilimumab monotherapy
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
Overall survival higher in group receiving pembrolizumab plus chemo versus chemotherapy alone
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
Improvement seen in overall structure preservation rate, orbit preservation rate, and skull base preservation rate
Gestational Hypertension Tied to Higher Later Risk for Cardiovascular Disease
No associations seen for preeclampsia or eclampsia or gestational diabetes
E-cigarette Use Tied to Poor Exercise Performance in Young Adults
Performance similar to that of tobacco cigarette smokers
Hot Flashes May Occur More Often in Second Half of Nightly Sleep
Authors say future research needed to see impact on REM sleep, cardiovascular disease
Sulthiame Beneficial for Symptoms of Obstructive Sleep Apnea
Reductions in primary efficacy end point of change in AHI during sleep linked with a ≥3 percent decrease in oxygen levels or arousal from sleep
